MedPath

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

Completed
Conditions
Primary Peritoneal Cancer
Fallopian Tube Cancer
Ovarian Cancer
Interventions
Behavioral: semi-structured interviews
Registration Number
NCT02928549
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to explore the experiences of Black women who receive care for ovarian cancer at Memorial Sloan Kettering Cancer Center, or "MSK" for short. The study consists of interviews with Black women who recently obtained some part of their ovarian cancer care at MSK.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Participant must have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer and treated by an MSK physician.
  • Participants must be able to provide verbal informed consent.
  • Participants must be 18 years of age or older.
  • Participants must self-identify as Black/African American.
  • Participant must be able to understand and speak in English
Read More
Exclusion Criteria
  • Inability or refusal to identify race/ethnicity.
  • Presence or development of a physical, cognitive or psychiatric deficit resulting in an inability to provide meaningful informed consent or to understand the study or complete the interview.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Black Women with Cancersemi-structured interviewsIn this formative qualitative research study we aim to use one-on-one semi-structured interviews with Black women diagnosed with ovarian cancer to learn about their experiences and their journey to accessing care at a high-volume ovarian cancer care center (HVC).
Primary Outcome Measures
NameTimeMethod
accessing care1 year

The study team will review and code the interview transcripts through a process of independent and collaborative thematic content analysis,\[15-18\] using ATLAS.ti (a qualitative data analysis software package) to facilitate the analysis process.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath